Center for Excellence in Host Pathogen Interactions
Project Number5P20GM113123-09
Contact PI/Project LeaderBRADLEY, DAVID S. Other PIs
Awardee OrganizationUNIVERSITY OF NORTH DAKOTA
Description
Abstract Text
Summary
This COBRE Phase 2 application proposes continued support of the UND Center for Excellence in Host-
Pathogen interaction (HPI). The long-term goal of this center is to develop a deeper understanding of host
responses to viral, bacterial and parasitic insults leading to acute and chronic inflammatory diseases. The vision
of this Center is to continue to inspire interest in the study of host-microbe interaction and perform paradigm-
shifting science that supports the notion that disease development is an interplay of the interaction between a
susceptible host, foreign insult and conducive microenvironment. In Phase 1 this center made significant
progress by expanding the number of investigators studying various aspects of infectious and inflammatory
diseases (from the initial group of 9 labs to now 18 labs). Since the funding of Phase 1 in 2016, this core group
of COBRE investigators has made significant contributions to the field by producing 169 publications,
$23,617,386 in extramural funding, and 74 speaking engagements (local, national and international). With the
project leader graduation success rate of 80% (4 out 6 investigators graduated with R01 funding) in Phase 1,
this Center will continue to promote research on host-microbe interaction by: 1) bringing together four young
investigators working cohesively in an integrative, collaborative, and multidisciplinary manner on research
encompassing extremely timely COVID-19 infection, intestinal dysbiosis in food allergy, gastrointestinal parasitic
infection, and viral interaction with respiratory epithelium; 2) enhance the innovative research capabilities of the
Center by supporting 3 existing Phase 1 Core facilities; 3) establishing a new Computational Data Analysis Core
to meet the emerging requirements of COBRE investigators; and 4) attract new investigators to the group by
supporting pilot grant mechanisms. The ultimate goal is to transition the HPI COBRE to a sustainable, well-
organized academic center which will serve as a conduit for increased interaction between investigators from
diverse backgrounds with a thematic interest in pursuing research on various aspects of host-microbe
interactions.
Public Health Relevance Statement
Project Narrative
The objective of this Phase 2 COBRE is to (1) support four independent, but complementary research projects
initiated by all early-stage/new investigators on host-pathogen interactions (HPI); (2) continue and expand
administrative and infrastructural support by nurturing the existing and new core facilities that are essential to
our COBRE group as well as to other biomedical researchers within and outside of UND; (3) implement
individualized mentoring program and career development opportunities for our junior investigator to achieve
independence and attain national/international recognition. Successful completion of these aims in Phase 2 will
solidify the independent, nationally recognized status of the HPI COBRE composed of a group of investigators
exploring novel areas of host-microbe interactions in human health and disease.
No Sub Projects information available for 5P20GM113123-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P20GM113123-09
Patents
No Patents information available for 5P20GM113123-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P20GM113123-09
Clinical Studies
No Clinical Studies information available for 5P20GM113123-09
News and More
Related News Releases
No news release information available for 5P20GM113123-09
History
No Historical information available for 5P20GM113123-09
Similar Projects
No Similar Projects information available for 5P20GM113123-09